Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.550
-0.010 (-0.39%)
At close: May 11, 2026, 4:00 PM EDT
2.550
0.00 (0.00%)
Pre-market: May 12, 2026, 7:18 AM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $147.65 million as of May 12, 2026. Its market cap has increased by 264.56% in one year.
Market Cap
147.65M
Enterprise Value
110.28M
1-Year Change
264.56%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $147.65M, a decrease of -4.19%. That is a compound annual growth rate of -0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 147.60M | 12.41% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 159.18M |
| Protalix BioTherapeutics | 156.31M |
| Molecular Partners AG | 153.08M |
| TuHURA Biosciences | 152.59M |
| Spruce Biosciences | 152.41M |
| Galectin Therapeutics | 145.48M |
| Equillium | 142.26M |
| Innate Pharma | 139.54M |